NO170079C - Fremgangsmaate for fremstilling av et krystallinsk torasemid - Google Patents

Fremgangsmaate for fremstilling av et krystallinsk torasemid

Info

Publication number
NO170079C
NO170079C NO863305A NO863305A NO170079C NO 170079 C NO170079 C NO 170079C NO 863305 A NO863305 A NO 863305A NO 863305 A NO863305 A NO 863305A NO 170079 C NO170079 C NO 170079C
Authority
NO
Norway
Prior art keywords
torasemid
crystalline
procedure
preparation
crystalline torasemid
Prior art date
Application number
NO863305A
Other languages
English (en)
Norwegian (no)
Other versions
NO863305D0 (no
NO170079B (no
NO863305L (no
Inventor
Fritz Topfmeier
Gustav Lettenbauer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO863305D0 publication Critical patent/NO863305D0/no
Publication of NO863305L publication Critical patent/NO863305L/no
Publication of NO170079B publication Critical patent/NO170079B/no
Publication of NO170079C publication Critical patent/NO170079C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO863305A 1985-08-17 1986-08-15 Fremgangsmaate for fremstilling av et krystallinsk torasemid NO170079C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853529529 DE3529529A1 (de) 1985-08-17 1985-08-17 Verfahren zur herstellung einer stabilen modifikation von torasemid

Publications (4)

Publication Number Publication Date
NO863305D0 NO863305D0 (no) 1986-08-15
NO863305L NO863305L (no) 1987-02-18
NO170079B NO170079B (no) 1992-06-01
NO170079C true NO170079C (no) 1992-09-09

Family

ID=6278766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863305A NO170079C (no) 1985-08-17 1986-08-15 Fremgangsmaate for fremstilling av et krystallinsk torasemid

Country Status (25)

Country Link
US (4) US4743693A (sv)
EP (1) EP0212537B1 (sv)
JP (2) JPS6245576A (sv)
KR (1) KR930009818B1 (sv)
AU (1) AU573454B2 (sv)
CA (1) CA1307277C (sv)
CS (2) CS259891B2 (sv)
DD (1) DD259858A5 (sv)
DE (2) DE3529529A1 (sv)
DK (1) DK162518C (sv)
ES (1) ES2001522A6 (sv)
FI (1) FI82189C (sv)
GR (1) GR862139B (sv)
HK (1) HK59994A (sv)
HU (1) HU195778B (sv)
IE (1) IE59237B1 (sv)
IL (1) IL79672A (sv)
LT (1) LT3596B (sv)
NO (1) NO170079C (sv)
NZ (1) NZ217172A (sv)
PL (1) PL146086B1 (sv)
PT (1) PT83186B (sv)
SU (1) SU1480766A3 (sv)
UA (1) UA7080A1 (sv)
ZA (1) ZA866151B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US6166045A (en) 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
CZ2002404A3 (cs) 1999-08-11 2002-06-12 Teva Pharmaceutical Industries Ltd. Polymorfní formy torsemidu
DE1292303T1 (de) 2000-02-17 2003-09-18 Teva Pharma Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
US6635765B2 (en) 2000-03-20 2003-10-21 Teva Pharmaceutical Industries, Ltd. Processes for preparing torsemide intermediate
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
HRP20000765A2 (en) * 2000-11-10 2002-06-30 Pliva D D Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (sv) * 2001-08-03 2004-03-06 Ranbaxy Lab
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
PT1465890E (pt) * 2002-11-18 2007-05-31 Teva Pharma Lansoprazole estável contendo mais de 500 ppm, até cerca de 3000 ppm de água e mais de 200 ppm, até cerca de 5000 de álcool
US7678816B2 (en) * 2003-02-05 2010-03-16 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
US10178893B1 (en) * 2013-06-14 2019-01-15 Scott Bradley Baker Shoe
FR3018688A1 (fr) * 2014-03-19 2015-09-25 Virbac Utilisation de torasemide a faible dose dans une composition veterinaire
EP3031471A1 (en) 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals
US12048677B2 (en) 2014-12-12 2024-07-30 Ceva Sante Animale Compositions and uses thereof for the treatment of heart failure in domestic animals
DK3173075T3 (en) * 2015-11-27 2019-01-21 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia PHARMACEUTICAL COMBINATION PREPARATION OF ACE INHIBITOR AND LOOPDIURETIC
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation

Also Published As

Publication number Publication date
CS594586A2 (en) 1988-03-15
UA7080A1 (uk) 1995-06-30
DK385586A (da) 1987-02-18
NZ217172A (en) 1989-02-24
NO863305D0 (no) 1986-08-15
SU1480766A3 (ru) 1989-05-15
KR930009818B1 (ko) 1993-10-11
CS259891B2 (en) 1988-11-15
HK59994A (en) 1994-07-08
LTIP898A (en) 1995-03-27
DK385586D0 (da) 1986-08-13
DE3529529A1 (de) 1987-02-19
USRE34580E (en) 1994-04-05
US4822807A (en) 1989-04-18
DE3529529C2 (sv) 1987-05-27
LT3596B (en) 1995-12-27
JPH0415205B2 (sv) 1992-03-17
US4743693A (en) 1988-05-10
NO170079B (no) 1992-06-01
AU573454B2 (en) 1988-06-09
PL261052A1 (en) 1987-11-02
IE862179L (en) 1987-02-17
HU195778B (en) 1988-07-28
FI82189C (sv) 1991-02-11
DK162518B (da) 1991-11-11
AU6105586A (en) 1987-02-19
PT83186A (de) 1986-09-01
JPH02191255A (ja) 1990-07-27
EP0212537A1 (de) 1987-03-04
CS419991A3 (en) 1992-06-17
PL146086B1 (en) 1988-12-31
GR862139B (en) 1986-12-30
ZA866151B (en) 1987-04-29
EP0212537B1 (de) 1990-01-03
DD259858A5 (de) 1988-09-07
IL79672A0 (en) 1986-11-30
FI863305A (fi) 1987-02-18
ES2001522A6 (es) 1988-06-01
IE59237B1 (en) 1994-01-26
DK162518C (da) 1992-03-30
FI863305A0 (fi) 1986-08-15
FI82189B (fi) 1990-10-31
JPS6245576A (ja) 1987-02-27
DE3667970D1 (de) 1990-02-08
JPH0643400B2 (ja) 1994-06-08
NO863305L (no) 1987-02-18
HUT42069A (en) 1987-06-29
USRE34672E (en) 1994-07-26
CA1307277C (en) 1992-09-08
PT83186B (pt) 1988-07-01
KR870002076A (ko) 1987-03-30
IL79672A (en) 1990-01-18

Similar Documents

Publication Publication Date Title
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO171826C (no) Fremgangsmaate for fremstilling av et stabilt nicorandilholdig preparat
NO170616C (no) Fremgangsmaate for fremstilling av et lyofilisert preparatav et antracyklinglykosid
NO851524L (no) Fremgangsmaate for fremstilling av fenetanolamin-forbindelser
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
TR22690A (tr) Bir guemues ihtiva eden katalizoeruen hazirlanmasina mahsus usul
ES539954A0 (es) Procedimiento de preparacion de un derivado de ciano-2-ben- cimidazol
TR22699A (tr) Bir guemues ihtiva eden katalizoeruen hazirlanmasina mahsus usul
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO169126C (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
NO864515L (no) Fremgangsmaate for fremstilling av heterocyliske oxazoloner
ES544005A0 (es) Procedimiento de preparacion de un complejo beta-ciclodexna de derivados de benceno-sulfonil-urea
IT8519652A0 (it) Procedimento per la preparazionedi alfa-omega-aloperfluorocarburi
FI92396B (sv) Nytt förfarande för framställning av metylendioxifenantrenföreningar
IT8647634A0 (it) Procedimento di preparazione di una fenilurea sostituita
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES551817A0 (es) Un procedimiento para la preparacion de derivados de dihidropiridina
ES553934A0 (es) Un procedimiento de preparacion de nuevos alfa-polihalocetoximas
ES528700A0 (es) Un procedimiento de preparacion de derivados de pirimidina
NO931587D0 (no) Fremgangsmaate for fremstilling av et metylendioksyfenantrenderivat
RO91930A2 (ro) Procedeu pentru prepararea butirolactonei
ES545493A0 (es) Procedimiento de preparacion de un derivado bencilaminico
NO171106C (no) Fremgangsmaate for fremstilling av 2-benzyl-1-nafthol
NO168806C (no) Fremgangsmaate for fremstilling av immunogent kompleks

Legal Events

Date Code Title Description
MK1K Patent expired